| __timestamp | Blueprint Medicines Corporation | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 152500000 |
| Thursday, January 1, 2015 | 48588000 | 187800000 |
| Friday, January 1, 2016 | 81131000 | 184000000 |
| Sunday, January 1, 2017 | 144687000 | 167700000 |
| Monday, January 1, 2018 | 243621000 | 218600000 |
| Tuesday, January 1, 2019 | 331450000 | 187400000 |
| Wednesday, January 1, 2020 | 326860000 | 177700000 |
| Friday, January 1, 2021 | 601033000 | 122000000 |
| Saturday, January 1, 2022 | 477419000 | 123100000 |
| Sunday, January 1, 2023 | 427720000 | 122500000 |
| Monday, January 1, 2024 | 341433000 |
Data in motion
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and Perrigo Company plc have demonstrated contrasting strategies in their R&D investments.
Blueprint Medicines has shown a remarkable upward trajectory, increasing its R&D expenses by over 1,200% from 2014 to 2023. This aggressive investment strategy peaked in 2021, with R&D spending reaching nearly 600% of its 2014 levels. In contrast, Perrigo Company plc has maintained a more conservative approach, with R&D expenses fluctuating modestly around a stable average, peaking in 2018.
This divergence highlights Blueprint's focus on pioneering new treatments, while Perrigo emphasizes steady, incremental innovation. As the pharmaceutical industry evolves, these strategic choices will shape each company's future in unique ways.
R&D Spending Showdown: Novartis AG vs Perrigo Company plc
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Gilead Sciences, Inc. vs Blueprint Medicines Corporation
Alnylam Pharmaceuticals, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Genmab A/S or Perrigo Company plc: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Perrigo Company plc and Xenon Pharmaceuticals Inc.